HSP90 Antibody (16F1) - BSA Free

Western Blot: HSP90 Antibody (16F1) [NBP1-97506]

Western Blot: HSP90 Antibody (16F1) [NBP1-97506] - Lane 1: MW marker, Lane 2: HSP90 native protein, Lane 3: HSP90b recombinant protein, Lane 4: HSP90alpha recombinant protein, Lane 5: HeLa (HS), Lane 6: L-929 (HS), Lane 7: Rat-2 (HS), Lane 8:RK-13 (HS).

Immunohistochemistry-Paraffin: HSP90 Antibody (16F1) [NBP1-97506]

Immunohistochemistry-Paraffin: HSP90 Antibody (16F1) [NBP1-97506] - Analysis of human spleen tissue stained with HSP90, mAb (16F1) at 10ug/ml.

Western Blot: HSP90 Antibody (16F1) - BSA Free [NBP1-97506] -

Ixazomib increases heat-shock proteins (HSPs) in mouse Schwann cellsImmortalized mouse Schwann cells treated with either 10 μg/mL Ixazomib (Ixa) or dimethyl sulfoxide (DMSO) for 24 h were subjected to isobaric tags for relative and absolute quantitation-mass spectrometry (iTRAQ-MS) proteomics.(A) Overview of the 66 significantly changed proteins (false discovery rate [FDR]-corrected p < 0.05) in four Ixazomib (Ixa) groups as compared with three DMSO groups. The heatmap represents the log2 (fold change [FC]) of the differentially expressed proteins in each group. The color key from blue to red represents the log2 (FC) from low to high. See Tables S3A and S3B for details.(B) Enrichment analysis of differentially expressed proteins. The vertical axis represents the pathway category and the horizontal axis represents the enrichment score [–log10 (P)] of the pathway. See Table S3C for details.(C) Volcano plot representing log10 (FDR) as a function of log2 (FC). The proteins identified with an FDR-value <0.05 and >1.0-fold are highlighted in red (up-regulated) or blue (down-regulated), with the dotted lines representing the boundary for identification.(D) Immunoblotting analyses using antibodies against poly-ubiquitin (polyUb), HSP40, HSP70, HSP90, and proteasome modulator 9 (PSMD9).(E) Quantification of relative protein amounts in (D). beta-Actin was used for internal control. Unpaired t test. Data are represented As means +/- SEM. ns, not significant, ∗p < 0.05, ∗∗p < 0.01, N = 3 for untreated (DMSO), and 4 for Ixazomib. Image collected and cropped by CiteAb from the following open publication (https://linkinghub.elsevier.com/retrieve/pii/S258900422301074X), licensed under a CC-BY license. Not internally tested by Novus Biologicals.